Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Feb;281(2):537-545.
doi: 10.1007/s00405-023-08242-z. Epub 2023 Sep 20.

Effectiveness of temperature-controlled radiofrequency neurolysis of the posterior nasal nerve to treat chronic rhinitis: a systematic review and meta-analysis

Do Hyun Kim  1 , Soo Whan Kim  1 , Sung Won Kim  1 , Gulnaz Stybayeva  2 , Se Hwan Hwang  3
Affiliations
Meta-Analysis

Effectiveness of temperature-controlled radiofrequency neurolysis of the posterior nasal nerve to treat chronic rhinitis: a systematic review and meta-analysis

Do Hyun Kim et al. Eur Arch Otorhinolaryngol. 2024 Feb.

Abstract

Purpose: This systematic review and meta-analysis evaluates the effect of TRNP on rhinitis-related symptoms.

Methods: We reviewed studies retrieved from PubMed, SCOPUS, Embase, the Web of Science, and the Cochrane database to June 2023. Studies that evaluated quality-of-life and rhinitis-related symptom scores before and after treatment were analyzed, as was one sham-treatment-controlled study.

Results: In total, 406 patients evaluated in five studies were analyzed. TRNP significantly improved rhinitis-related symptoms-congestion, itching, rhinorrhea, and sneezing-for up to 12 months after treatment, compared to before treatment. The most significant symptom decreases were those of rhinorrhea and nasal congestion. Rhinitis-related symptoms had improved significantly at 3 months after TRNP, compared to sham surgery. TRNP improved disease-specific quality-of-life scores on the Rhinoconjunctivitis Quality of Life Questionnaire at 6 months after treatment, compared to before treatment. The rates of clinical improvement in terms of all nasal symptoms (reduction > 30% from baseline) and in quality of life (minimal clinically important difference > 0.4) after TRNP were 79% and 84% respectively. There was no severe adverse event associated with either device use or the overall procedure.

Conclusions: TRNP treatment improved subjective symptoms related to rhinitis, especially rhinorrhea and nasal congestion, and also improved disease-specific quality-of-life scores.

Keywords: Equipment and supplies; Meta-analysis; Nose; Quality of life; Rhinitis.

PubMed Disclaimer

References

    1. Settipane RA, Charnock DR (2007) Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol 19:23–34 - PubMed
    1. Greiwe JC, Bernstein JA (2019) Allergic and mixed rhinitis: diagnosis and natural evolution. J Clin Med. https://doi.org/10.3390/jcm8112019 - DOI - PubMed - PMC
    1. Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, Dixon T, Durham SR, Farooque S, Jones N, Leech S, Nasser SM, Powell R, Roberts G, Rotiroti G, Simpson A, Smith H, Clark AT (2017) BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007). Clin Exp Allergy 47:856–889. https://doi.org/10.1111/cea.12953 - DOI - PubMed
    1. Patel GB, Kern RC, Bernstein JA, Hae-Sim P, Peters AT (2020) Current and future treatments of rhinitis and sinusitis. J Allergy Clin Immunol Pract 8:1522–1531. https://doi.org/10.1016/j.jaip.2020.01.031 - DOI - PubMed - PMC
    1. Marshak T, Yun WK, Hazout C, Sacks R, Harvey RJ (2016) A systematic review of the evidence base for vidian neurectomy in managing rhinitis. J Laryngol Otol 130(Suppl 4):S7-s28. https://doi.org/10.1017/s0022215116008008 - DOI - PubMed

LinkOut - more resources